Cyclosporine-assisted adipose-derived mesenchymal stem cell therapy to mitigate acute kidney ischemia-reperfusion injury.
Wallace, Christopher G
JournalStem Cell Research & Therapy
Research Support, Non-U.S. Gov't
RightsArchived with thanks to Stem cell research & therapy
MetadataShow full item record
This study tested the hypothesis that cyclosporine (CsA)-supported syngeneic adipose-derived mesenchymal stem cell (ADMSC) therapy offered superior attenuation of acute ischemia-reperfusion (IR) kidney injury to either therapy alone.